Interventional Radiology Imaging

Which Vein Is Best for Short-Term Central Access in Acutely Ill Patients?

·
Which Vein Is Best for Short-Term Central Access in Acutely Ill Patients?

It’s 2 AM in the intensive care unit, and your patient with severe sepsis is becoming more unstable. Their peripheral intravenous lines are failing, and they urgently need vasopressors, broad-spectrum antibiotics, and frequent lab draws. You anticipate they will require this level of support for at least the next week, but hopefully not longer than two. You need to place a central venous catheter, but the optimal site isn’t immediately obvious. This article provides a clinical workflow for selecting a central venous access site in an acutely ill patient requiring therapy for two weeks or less, grounded in the American College of Radiology (ACR) Appropriateness Criteria. For this specific scenario, placement in the Right or left internal jugular vein is rated Usually Appropriate.

Who Fits This Clinical Scenario for Central Line Site Selection?

This guidance is for clinicians managing an acutely ill patient who requires reliable central venous access for a short, defined period—typically less than 14 days. The primary indication is the need for therapies that cannot be safely administered through a peripheral line or the failure of peripheral access altogether.

Inclusion criteria for this workflow:

  • Acute, serious illness: Conditions like sepsis, septic shock, acute respiratory distress syndrome (ARDS), or major post-operative care.
  • Short-term therapy anticipated: The expected duration of central access is two weeks or less.
  • Indication for central access: The patient requires infusion of vesicants or irritants (e.g., vasopressors, concentrated electrolytes), hemodynamic monitoring, frequent phlebotomy, or has exhausted peripheral access options.

This workflow does NOT apply to patients with different clinical needs, such as:

  • Long-term chemotherapy: A patient with a new cancer diagnosis needing weekly infusions for several months would be better served by a different device, such as a tunneled catheter or an implanted port.
  • Renal replacement therapy: Patients requiring hemodialysis need a specific high-flow dialysis catheter, and site selection criteria prioritize long-term vein preservation, which alters the decision-making process.
  • Long-term total parenteral nutrition (TPN): Patients who will require TPN for many weeks or months have distinct needs related to infection risk and catheter longevity, often favoring tunneled devices.

These other presentations are addressed in separate ACR Appropriateness Criteria variants.

What Clinical Needs Drive Site Selection in Acute Illness?

In this scenario, the choice of access site is not driven by a diagnostic question but by a set of urgent therapeutic requirements. The “differential” here is an assessment of the patient’s immediate and near-term physiological needs, which collectively argue for a central line over peripheral options.

A primary driver is the need for reliable administration of vesicants and irritants. Medications like vasopressors (e.g., norepinephrine, epinephrine), concentrated potassium chloride, and hypertonic saline can cause severe tissue necrosis if they extravasate from a peripheral IV. Placing a catheter tip in a large-caliber central vein like the superior vena cava (SVC) ensures rapid dilution and minimizes this risk.

Another key consideration is the potential need for hemodynamic monitoring. While the use of central venous pressure (CVP) to guide fluid resuscitation has evolved, it remains a tool in select complex cases. An appropriately placed central catheter is a prerequisite for obtaining these measurements.

In critically ill patients, frequent phlebotomy is a certainty. A central line with multiple lumens provides a durable, pain-free way to draw daily labs, preserving the patient’s limited peripheral veins and reducing discomfort from repeated needle sticks.

Finally, many acutely ill patients present with inadequate peripheral access due to factors like anasarca, obesity, or a history of frequent hospitalizations. In these cases, a central line is not just optimal but necessary for any intravenous therapy.

Why Is the Internal Jugular Vein a Recommended Site for Short-Term Access?

The ACR panel rates the Right or left internal jugular (IJ) vein as Usually Appropriate for this scenario, making it a primary choice. The rationale is based on a favorable balance of accessibility, safety, and functionality for short-term, non-tunneled catheters.

The IJ vein offers a large diameter and a direct, straight anatomical path to the superior vena cava, particularly from the right side. This linear course facilitates correct catheter tip placement at the cavoatrial junction and is thought to reduce the risk of vessel wall injury or thrombosis compared to more tortuous routes.

Crucially, the IJ vein is readily accessible with real-time ultrasound guidance. This has become the standard of care for placement, as it dramatically reduces the rate of mechanical complications. Ultrasound allows the operator to confirm patency, avoid overlying structures like the carotid artery, and guide the needle into the vein in a single, controlled pass. This minimizes the risk of arterial puncture, hematoma, and pneumothorax.

Other sites are also considered, but with important caveats for this specific clinical context:

  • Right or left subclavian vein: Also rated Usually Appropriate. This site is often favored for its lower infection rates in some studies and potentially greater patient comfort. However, it carries a higher risk of pneumothorax, and because it passes through a non-compressible space between the clavicle and first rib, any bleeding from an inadvertent arterial puncture can be difficult to control. It is also associated with a higher risk of long-term central venous stenosis.
  • Right or left femoral vein: Rated May be appropriate. The femoral approach is technically straightforward and avoids the risks of pneumothorax. However, it has been historically associated with a higher risk of catheter-related bloodstream infections (CRBSI) and deep vein thrombosis (DVT), particularly in patients with a high body mass index. It is often reserved as a bailout site or for emergent situations when the neck and chest are inaccessible.

This procedure does not involve ionizing radiation.

What’s Next After Catheter Placement? Downstream Workflow

Successful placement of a short-term central venous catheter is the beginning, not the end, of the workflow. The next steps focus on confirmation, maintenance, and planning for removal.

  • If placement is successful: The immediate next step is to confirm the catheter tip position. A post-procedure chest radiograph is the standard method to ensure the tip is located in the lower SVC or at the cavoatrial junction and to rule out iatrogenic pneumothorax. Once the position is confirmed, the catheter can be used for infusions, monitoring, and phlebotomy. Daily assessment of the insertion site for signs of infection and evaluation of the ongoing need for the line are critical.
  • If initial access fails: If the chosen site (e.g., right IJ) is thrombosed or inaccessible, the next step is to assess the contralateral IJ vein. If both IJ veins are unsuitable, the workflow proceeds to an alternative site rated Usually Appropriate (subclavian vein) or May be appropriate (femoral vein), depending on patient-specific factors and operator comfort.
  • If a complication occurs: In the event of a complication like a large hematoma, arterial puncture, or pneumothorax, the priority is immediate patient stabilization. This may involve applying direct pressure, consulting vascular surgery, or placing a chest tube. Further attempts at central access should be deferred until the patient is stable.

The overarching goal is to use the central line for the shortest duration necessary and to remove it as soon as it is no longer clinically indicated to minimize the risk of infection and thrombosis.

Pitfalls to Avoid (and When to Get Help)

Several common pitfalls can complicate short-term central venous access. Awareness of these issues can improve patient safety and outcomes.

  • Forgoing ultrasound guidance: Attempting “blind” or landmark-based placement significantly increases the risk of mechanical complications like arterial puncture and pneumothorax. Real-time ultrasound is the modern standard of care.
  • Inadequate sterility: Breaching sterile technique during insertion is a primary driver of central line-associated bloodstream infections (CLABSI). Strict adherence to a full sterile barrier protocol is mandatory.
  • Incorrect tip placement: A catheter tip placed too high (in the upper SVC or brachiocephalic vein) increases thrombosis risk, while a tip placed too low (in the right atrium) can cause arrhythmias or cardiac perforation. Always confirm with a chest radiograph.
  • Ignoring contraindications: Failing to assess for coagulopathy, thrombocytopenia, or overlying site infection before attempting placement can lead to severe bleeding or infectious complications.

If you encounter significant difficulty with access, suspect a major complication, or are managing a patient with known complex central venous anatomy, escalate immediately by consulting a more experienced operator or an interventional radiology service.

Related ACR Topics and Tools

This article covers one specific scenario in depth. For a broader view of all clinical variants and device types, please consult the parent topic guide. The following resources can help you apply these principles in your practice.

Frequently Asked Questions

Why is the right internal jugular vein often preferred over the left?

The right internal jugular (IJ) vein is generally preferred because it follows a straighter, more direct path to the superior vena cava (SVC) and right atrium. This anatomical advantage can make catheter insertion smoother and may reduce the risk of the catheter tip abutting the vessel wall, potentially lowering the risk of thrombosis or vessel injury.

Is a chest X-ray always necessary after placing an IJ or subclavian line?

Yes, a post-procedure chest radiograph is considered standard of care after placing a central line in the internal jugular or subclavian vein. Its purpose is twofold: to confirm the catheter tip is in the correct position (ideally at the cavoatrial junction) and to rule out procedural complications, most importantly a pneumothorax.

What if my patient is on anticoagulation? Can I still place a central line?

Placement of a central line in a patient on anticoagulation requires a careful risk-benefit analysis. The internal jugular and femoral sites are generally preferred over the subclavian site in these patients because they are compressible; if bleeding occurs, direct pressure can be applied. The decision should be made in consultation with institutional guidelines and, if necessary, a hematology or coagulation expert.

How does this guidance change if the patient needs access for 4-6 weeks instead of just 2?

If the anticipated duration of therapy extends beyond 2-3 weeks, a non-tunneled central catheter is often no longer the best choice due to infection risk. For intermediate-term access (weeks to a few months), a peripherally inserted central catheter (PICC) or a tunneled catheter would be more appropriate. This represents a different clinical scenario with its own set of device and site selection criteria.

Can I use the external jugular vein instead of the internal jugular vein?

The external jugular (EJ) vein is rated as *May be appropriate* by the ACR for this scenario. While it is more superficial and can sometimes be accessed without ultrasound, it is often smaller, more tortuous, and has valves that can make advancing a guidewire and catheter into the central circulation difficult. It is generally considered a secondary option if the internal jugular or other primary sites are inaccessible.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026